Cardinal Healthvs.McKesson
CAH vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 2.0× larger than Cardinal Health by market cap; McKesson trades at the lower P/E (23.3 vs 31.4).
Side by side
| CAH | MCK | |
|---|---|---|
| Market cap | $53.8B | $107B |
| Price | $238.96 | $930.25 |
| Today | +2.9% | +2.2% |
| Return YTD | +13.0% | +11.0% |
| Return 1Y | +48.2% | +21.4% |
| Since June 26, 2026 | +0.4% | +21.8% |
| P/E | 31.4 | 23.3 |
| P/S | 0.2 | 0.3 |
| P/B | 53.9 | 18.2 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Cardinal HealthCAH
Two businesses sit under one roof. One distributes medicines through the healthcare system, the other manufactures medical products and consumables, with pharmacy services alongside.
Full CAH profile →McKessonMCK
Medicines reach the counter through wholesalers, and McKesson is one of them: its customers run from pharmacies to hospitals and clinics across the US. Alongside distribution it sells services to pharmacy operators and runs an oncology network.
Full MCK profile →More CAH & MCK comparisons
Other head-to-heads in the Distribution & pharmacy infrastructure segment.